Interaction between a chromosome 10 RET enhancer and chromosome 21 in the down syndrome-hirschsprung disease association

56Citations
Citations of this article
30Readers
Mendeley users who have this article in their library.

Abstract

Individuals with Down syndrome (DS) display a 40-fold greater risk of Hirschsprung disease (HSCR) than the general population of newborns implicating chromosome 21 in HSCR etiology. Here we demonstrate that the RET enhancer polymorphism RET 19.7 (rs2435357:C>T) at chromosome 10q11.2 is associated with HSCR in DS individuals both by transmission disequilibrium (P = 0.0015) and case-control (P = 0.0115) analysis of matched cases. Interestingly, the RET19.7 T allele frequency is significantly different between individuals with DS alone (0.26 ±0.04), HSCR alone (0.61 ±0.04), and those with HSCR and DS (0.41 ± 0.04), demonstrating an association and interaction between RETand chromosome 21 gene dosage. This is the first report of a genetic interaction between a common functional variant (rs2435357) and a not infrequent copy number error (chromosome 21 dosage) in two human developmental disorders. © 2009 Wiley-Liss, Inc.

Cite

CITATION STYLE

APA

Arnold, S., Pelet, A., Amiel, J., Borrego, S., Hofstra, R., Tam, P., … Chakravarti, A. (2009). Interaction between a chromosome 10 RET enhancer and chromosome 21 in the down syndrome-hirschsprung disease association. Human Mutation, 30(5), 771–775. https://doi.org/10.1002/humu.20944

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free